Navigation Links
Genzyme Reports Strong First-Quarter Growth

n-GAAP earnings are projected

to rise to approximately $7.00 per diluted share by 2011.

-- Myozyme sales are expected to be approximately $275-$285 million this

year, compared to prior guidance of $320-$330 million.

-- Non-GAAP earnings per share for the second quarter are expected to be

in the mid $0.90s, reflecting ongoing investments to drive future

growth. These include investments in the U.S. launch of Renvela(R)

(sevelamer carbonate) and the expanded European introduction of

Clolar(R) (clofarabine), as well as investments in late-stage clinical

trials-particularly the phase 3 study of alemtuzumab for multiple

sclerosis. This estimate also reflects the constraints on U.S. Myozyme


First-Quarter Product Sales

-- Within the Therapeutics business, worldwide demand for Myozyme remains

robust two years into the product's launch. First-quarter sales rose

78 percent despite the delay in U.S. approval for 2000L production

capacity. Sales increased to $67.3 million from $37.9 million in the

period a year ago, driven by the number of new patients starting

therapy. As announced, the FDA will require Genzyme to submit a BLA to

obtain U.S. commercial approval for Myozyme produced at the 2000L

scale. The agency is expected to act on the application by the end of

this year.

-- First-quarter sales of Cerezyme(R) (imiglucerase for injection) rose 15

percent to $304.3 million, compared with $263.8 million in the previous

first quarter.

-- Sales of Fabrazyme(R) (agalsidase beta) grew 16 percent in the quarter,

rising to $116.5 million from $100.7 million in the first quarter last

year. Fabrazyme has captured more than a two thirds share of the

international market for Fabry disease treatment based on compelling

clinical dat

SOURCE Genzyme Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Genzyme to Build New R&D Center in Beijing
2. Genzyme Provides Update on Myozyme(R) Manufacturing
3. Genzyme Withdraws Bioenvisions European Filing of Evoltra(R) in Elderly AML Patients
4. Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients
5. Genzyme and Isis Announce Hart-Scott-Rodino Approval of Collaboration
6. Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
7. BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
8. Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM)
9. Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation
10. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
11. Genzyme and Sunway to Collaborate on Gene Therapy Program in China
Post Your Comments:
(Date:7/29/2014)... The prestigious "Discovery or Exploration in History Award" ... Juliana Hillis and Kaylie O’Connell, students at Stoneham High ... Egg, Everything: America’s First IVF Baby". This project was ... History Day program during a week-long final competition judged ... D.C. , The growing popularity of the assisted reproductive ...
(Date:7/28/2014)... developed by researchers at the University of Cambridge, could ... realm of science fiction, such as invisibility cloaks and ... a reality for quite some time, the technique which ... a few billionths of a metre across can be ... them, and works on large chunks all at once. ...
(Date:7/28/2014)... Annapolis Junction, MD (PRWEB) July 28, 2014 ... leader in personalized medicine, will be exhibiting data and ... this year’s International Spine Intervention Society’s (ISIS) ... July 30th-August 3rd, at the Hyatt Regency, in Orlando, ... enhance the knowledge and clinical competence of physicians who ...
(Date:7/28/2014)... Boston, MA (PRWEB) July 28, 2014 ... with two researchers to further develop potential treatments for ... brain tumor, in combination with their patented vaccine platform, ... and Duke University, are based on the work of ... of Neurosurgery at The Preston Robert Tisch Brain Tumor ...
Breaking Biology Technology:In Vitro Fertilization (IVF) was the Subject of This Year’s Winning Entry for the Prestigious Library of Congress “Discovery or Exploration in History Award” 2In Vitro Fertilization (IVF) was the Subject of This Year’s Winning Entry for the Prestigious Library of Congress “Discovery or Exploration in History Award” 3Building 'invisible' materials with light 2Proove Biosciences Exhibits Industry Leading Data and Research at International Spine Intervention Society’s 22nd Annual Scientific Meeting 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 3String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 4
... and minerals. Image courtesy of Brain Twist ... an aid to holding off the cold and flu is ... York-based Brain Twist Inc. is launching Defense Vitamin ... boosting beverage utilizing the FreshCan technology of Degussa FreshTech ...
... Circuit (CAFC) issued a patent-law decision last month that inevitably ... will raise the bar for proving gene and protein related ... fragment sequences were useful. Most notably whether the gene fragments ... patent law. , ,The CAFC ruled against the patent applicants ...
... is bombarded with more than 3,000 advertisements each day. So ... most relevant ones. , ,Marketers used to view advertising ... meant blasting the same ad across mass media as often ... huge audience several times. , ,Jay Townley, president of ...
Cached Biology Technology:Court bars patent protection for certain gene fragments 2Court bars patent protection for certain gene fragments 3Court bars patent protection for certain gene fragments 4Turning ads into sales: Context is king 2Turning ads into sales: Context is king 3Turning ads into sales: Context is king 4
(Date:7/29/2014)... major role in locomotion. Swimming microorganisms, such as bacteria ... compared to the viscous forces exerted by the surrounding ... challenge. Now, scientists have found that the direction of ... that induced by a viscoelastic fluid. These findings have ... Nadal from the Alternative Energies and Atomic Energy Commission ...
(Date:7/29/2014)... But on the remote UK overseas territory of Ascension ... is undergoing something of a renaissance. , Writing in ... the University of Exeter and Ascension Island Government Conservation ... at the remote South Atlantic outpost has increased by ... the 1970s. As many as 24,000 nests are now ...
(Date:7/29/2014)... method to create DNAprotein conjugates. The method can ... , DNA linked to proteins including antibodies ... used in diagnostic techniques, nanotechnology and other disciplines. ... can be used for purposes such as ... The method also provides easier access to handling ...
Breaking Biology News(10 mins):Optimum inertial self-propulsion design for snowman-like nanorobot 2Major turtle nesting beaches protected in 1 of the UK's far flung overseas territories 2New method provides researchers with efficient tool for tagging proteins 2
... at The Wistar Institute announce the release of an ... along a DNA strand that tell a cell,s transcription ... a particular protein. The Mammalian Promoter Database (MPromDb) ... publicly available data on human and mouse genomics. MPromDb ...
... Carnegie Mellon University,s Manojkumar Puthenveedu has discovered the mechanism ... understanding signaling receptor function. Writing in the journal Cell, ... signaling receptor travels back to the cell membrane after ... live on the cell membrane waiting to be matched ...
... Spanish . , The AZTI-Tecnalia technological centre, in ... dairy product companies within the FUTURAL project, has verified that, ... of a number of dairy products, high pressure technology is ... Tecnolat, the results, especially with ready-to-eat fruit products and in ...
Cached Biology News:New annotated database sifts through mountains of sequencing data to find gene promoters 2New annotated database sifts through mountains of sequencing data to find gene promoters 3Carnegie Mellon researchers discover mechanism for signaling receptor recycling 2Carnegie Mellon researchers discover mechanism for signaling receptor recycling 3Research shows positive results with high pressure technology for certain dairy products 2
Bovine Brain Microvascular Endothelial Cells (BBMVEC) (>500,000 cells)...
The improved design and new mechanical solutions of Finnpipette Focus Multichannel Plus improves accuracy and precision.In these low volume multichannel pipettes, the super blow-out function ensures ...
... solution. Cleaves a-(1-3)- and ... and glycoproteins. It is particularly efficient for ... pH must be neutral or above, for ... Unit Definition: One unit will hydrolyze ...
... is specific for human cardiac troponin subunit T, ... signals responsible for contraction of cardiac muscle. It ... in human cells. It also cross-reacts with human ... Antigen: Highly purified human cardiac troponin ...
Biology Products: